JPH07121195B2 - healthy food - Google Patents
healthy foodInfo
- Publication number
- JPH07121195B2 JPH07121195B2 JP61026671A JP2667186A JPH07121195B2 JP H07121195 B2 JPH07121195 B2 JP H07121195B2 JP 61026671 A JP61026671 A JP 61026671A JP 2667186 A JP2667186 A JP 2667186A JP H07121195 B2 JPH07121195 B2 JP H07121195B2
- Authority
- JP
- Japan
- Prior art keywords
- freeze
- kefir
- dried
- weight
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Dairy Products (AREA)
Description
【発明の詳細な説明】 〔発明の技術分野〕 本発明は健康食品に関し、より詳細には凍結乾燥ケフイ
ア・ヨーグルトを有効主成分とする健康食品に関する。TECHNICAL FIELD OF THE INVENTION The present invention relates to health foods, and more particularly to health foods containing freeze-dried kefir yogurt as an active ingredient.
近年の健康食品ブームを反映して数多くの健康食品が市
販されている。Many health foods are commercially available, reflecting the recent boom in health foods.
しかしながら、これら健康食品の多くは植物性成分また
は動物性成分を有効成分とするものであり、発酵乳を有
効成分とする固体状の健康食品はほとんど知られていな
い。However, most of these health foods contain a plant ingredient or an animal ingredient as an active ingredient, and almost no solid health food containing fermented milk as an active ingredient is known.
一方、本発明者等は先に凍結乾燥ヨーグルトと、この凍
結乾燥ヨーグルトを発酵乳・ケフイアから製造する方法
について提案し（特願昭60−223987号、昭和60年10月８
日）、この凍結乾燥ヨーグルトが抗腫瘍活性、抗血栓症
作用および免疫賦活性等の生理効果を有し、特にマイト
マイシンに匹敵する抗腫瘍活性を有することを明らかに
した。On the other hand, the present inventors have previously proposed freeze-dried yogurt and a method for producing this freeze-dried yogurt from fermented milk and kefir (Japanese Patent Application No. 60-223987, October 8, 1985).
It has been clarified that this freeze-dried yogurt has physiological effects such as antitumor activity, antithrombotic activity and immunostimulatory activity, and in particular has an antitumor activity comparable to mitomycin.
しかしながら、この凍結乾燥ヨーグルトは粉末状である
ために摂取の際に飛散したり、一定量を秤量するのに手
間がかかる等の問題点があつた。However, since this freeze-dried yogurt is in the form of powder, there are problems that it scatters when ingested and it takes time to weigh a certain amount.
本発明は上記従来の欠点を解消すべくなされたものであ
り、先に提案した凍結乾燥ヨーグルトを有効主成分と
し、これに他の生理効果を有する補助剤および賦形剤を
添加して飛散することがなく、一定量を容易に摂取する
ことができる健康食品を提供することを目的とするもの
である。The present invention has been made to solve the above-mentioned conventional drawbacks, in which the previously proposed freeze-dried yogurt is used as an effective main component, and auxiliary agents and excipients having other physiological effects are added thereto and scattered. The purpose of the present invention is to provide a health food that can be easily ingested in a certain amount.
上記目的を達成する本発明の健康食品は、凍結乾燥ケフ
イア・ヨーグルト（以下、凍結乾燥ケフイアと略記す
る）と補助剤および賦形剤とからなり、該補助剤がエゾ
ウコギ・エキス、トナカイ角粉末およびチコリ・エキス
から選ばれた少なくとも１種であることを特徴とするも
のである。The health food of the present invention that achieves the above object comprises freeze-dried kefir yogurt (hereinafter abbreviated as freeze-dried kefir), an adjuvant and an excipient, wherein the adjuvant is eleuthero extract, reindeer horn powder and It is characterized by being at least one kind selected from chicory extract.
本発明において使用される凍結乾燥ケフイア（Kefir）
は、乳状の芳香を有する白色〜乳白色の粉末状であり、
牛乳にケフイア菌スターターを接種して発酵乳（ケフイ
ア）を製造し、得られたケフイアを凍結乾燥することに
よつて製造することができ、粉末状である。Freeze-dried Kefir used in the present invention
Is a white to milky white powder having a milky aroma,
It can be produced by inoculating cow's milk with a kefiria starter to produce fermented milk (kefir), and freeze-drying the obtained kefir, which is in powder form.
また本発明における補助剤とは、有効主成分である凍結
乾燥ケフイアが有する生理効果に、更に他の生理効果を
加えて健康食品としての汎用性を満足させることを目的
として添加されるものであり、従来、健康食品または漢
方薬品として多くの動物性または植物性成分のものが知
られている。本発明は、この補助剤としてエゾウコギ・
エキス、トナカイ角粉末およびチコリ・エキスを選択使
用することを特徴とする。Further, the adjuvant in the present invention, in addition to the physiological effect of freeze-dried kefir that is the active ingredient, is added for the purpose of satisfying the versatility as a health food by adding other physiological effects. Heretofore, many animal or plant components have been known as health foods or herbal medicines. The present invention uses the eleuthero
The feature is that the extract, reindeer horn powder and chicory extract are selectively used.
これら補助剤は単一種類を添加しても良いし、複数種類
を使用することもできるが、これら３種の添加が好まし
い。A single type of these auxiliary agents may be added or a plurality of types may be used, but addition of these three types is preferable.
ここでエゾウコギ・エキスとは、血流をを改善する効果
を有するとして古くから使用されており、下記のように
して製造される。Here, the eleuthero extract has been used for a long time as having an effect of improving blood flow, and is produced as follows.
即ち、ウコギ科（Arflifceae）に属するエゾウコギ〔Ac
anthopanax senticosus Harms.（Eleut herococus sent
icosus Maxim）、シベリヤおよび中国東北部に主として
産する〕の根および根茎を粗細し、例えば、この粗細品
100Kgに水500を加え、90〜100℃で３時間浸出した後
に濾過すると浸出液約400が得られる。That is, Eleuthero [Ac which belongs to Araliaceae (Arflifceae)]
anthopanax senticosus Harms. (Eleut herococus sent
icosus Maxim), which is mainly produced in Siberia and northeastern China].
Water 500 is added to 100 kg, leached at 90 to 100 ° C. for 3 hours, and then filtered to obtain about 400 leachate.
一方、浸出残留物に再び水300を加え、90〜100℃で１
時間浸出し、濾過すると浸出溶液300が得られる。On the other hand, add 300 water again to the leaching residue and
The leaching solution 300 is obtained by leaching and filtering for a time.
両浸出液を合併し、60℃以下で約20まで減圧濃縮し、
濃縮液を噴霧乾燥し、乾燥物を篩過すると均一な粉末約
5Kgが得られる。Combined both exudates, concentrated under reduced pressure to about 20 below 60 ℃,
Spray the concentrated solution and sieve the dried product to obtain a uniform powder.
5 kg is obtained.
また、トナカイ角粉末は従来から強壮作用を有するとさ
れており、主としてフインランド産から輸入される角を
粗細し、更にハンマーミルで粉砕し、100メツシュで篩
過すると均一な粉末が得られる。なお、製造過程中に適
宜、殺菌工程が付加される。Further, reindeer horn powder has been said to have a tonic effect from the past, and it is possible to obtain a uniform powder by coarsely crushing the horns mainly imported from Finland, crushing them with a hammer mill, and sieving with 100 mesh. A sterilization step is appropriately added during the manufacturing process.
更にチコリ・エキスとは、免疫賦活性を有するとして古
くから主としてヨーロツパで使用されており、次のよう
にして製造される。Chicory extract has been used mainly in Europe for a long time because it has immunostimulatory activity, and is produced as follows.
即ち、キク科（Conpositae）に属するチコリ（Cichoriu
m Intylous L.、主としてヨーロツパに産する）の葉お
よび根を粗細し、例えば、この粗細物100Kgに水800を
加え、90〜100℃で３時間浸出し、濾過すると浸出浴液7
00が得られる。That is, chicory (Cichoriu) belonging to the family Asteraceae (Conpositae)
m Intylous L. (produced mainly in Europe) leaves and roots are finely crushed. For example, 100 kg of this finely ground product is added with 800 water, leached at 90 to 100 ° C. for 3 hours, and filtered to obtain a leaching bath solution.
You get 00.
浸出残留物に再び水500を加え、90〜100℃で１時間浸
出し、濾過すると浸出液約400が得られる。Water 500 is again added to the leaching residue, leaching is performed at 90 to 100 ° C. for 1 hour, and filtration is performed to obtain about 400 leaching liquid.
両浸出液を合併し、60℃以下で約35Kgまで減圧濃縮する
とシロツプ状の軟エキスが得られる。When both exudates are combined and concentrated under reduced pressure to about 35 Kg at 60 ° C or lower, a soft syrupy extract is obtained.
次に本発明における賦型剤としては、乳糖、澱粉等が挙
げることができ、かかる賦形剤は単一種または複数種の
併用で使用される。Next, examples of the excipient in the present invention include lactose, starch and the like, and such excipients are used alone or in combination of two or more.
本発明の健康食品における、これら凍結乾燥ケフイア、
補助剤および賦形剤の配合割合は下記第１表のとおりで
ある。In the health food of the present invention, these freeze-dried kefir,
The blending ratio of the auxiliary agent and the excipient is as shown in Table 1 below.
第１表 凍結乾燥ケフイア・・通常では30〜50重量％、好ましく
は35〜45重量％ 補助剤・・・・・・通常、７〜15重量％、好ましくは９
〜14重量％ 賦形剤・・・通常では40〜55重量％、好ましくは45〜55
重量％ そして、補助剤として、エゾウコギ・エキス、トナカイ
角粉末およびチコリ・エキスを用い、賦形剤として乳糖
および澱粉を使用した場合の本発明の健康食品の配合割
合を、下記第２表に示す。Table 1 Freeze-dried kefir: usually 30 to 50% by weight, preferably 35 to 45% by weight Auxiliary agent: usually 7 to 15% by weight, preferably 9
Excipients ... usually 40-55% by weight, preferably 45-55%
% The composition ratio of the health food of the present invention is shown in Table 2 below, in which the eleuthero extract, reindeer horn powder and chicory extract are used as auxiliary agents and lactose and starch are used as excipients. .
第２表 凍結乾燥ケフイア・・通常、35〜50重量％、好ましくは
35〜45重量％、 エゾウコギ・エキス・・通常では1.5〜4.0重量％、好ま
しくは2.0〜3.5重量％、 トナカイ角粉末・・通常0.3〜1.0重量％、好ましくは0.
4〜0.8重量％、 チコリ・エキス・・通常、5.5〜10重量％、好ましくは
6.5〜9.5重量％、 乳糖・・・・・通常は30〜38重量％、好ましくは32〜37
重量％、 澱粉・・・・・通常、10〜18重量％、好ましくは12〜17
重量％ 凍結乾燥ケフイアの配合量が30重量％に満たないと、こ
の凍結乾燥ケフイアが本来有している抗腫瘍活性、抗血
栓症作用および免疫賦活効果等の生理効果が低下し、ま
た50重量％を越えて添加しても添加量増加による上記生
理効果の増大が特に認められない。Table 2 Freeze-dried kefir, usually 35-50% by weight, preferably
35 to 45% by weight, Eleuthero extract, usually 1.5 to 4.0% by weight, preferably 2.0 to 3.5% by weight, reindeer horn powder, usually 0.3 to 1.0% by weight, preferably 0.
4 to 0.8% by weight, chicory extract, usually 5.5 to 10% by weight, preferably
6.5-9.5% by weight, lactose ... usually 30-38% by weight, preferably 32-37
% By weight, starch ... usually 10-18% by weight, preferably 12-17
% If the content of freeze-dried kefir is less than 30% by weight, the physiological effects such as antitumor activity, antithrombotic effect and immunostimulatory effect originally possessed by this freeze-dried kefir will decrease, and Even if it is added in excess of%, no particular increase in the above physiological effects due to the increase in the amount added is recognized.
エゾウコギ・エキスの添加量が1.5重量％未満では、血
流改善効果を期待することができず、4.0重量％を越え
ても効果の増大は特に見られない。If the added amount of eleuthero extract is less than 1.5% by weight, the effect of improving blood flow cannot be expected, and if it exceeds 4.0% by weight, the effect is not particularly increased.
また、トナカイ角粉末の使用量が0.3重量％に満たない
と、強壮作用が認められず、1.0重量％を越えて添加し
ても特に顕著を効果上の差異は認められない。Further, if the amount of the reindeer horn powder used is less than 0.3% by weight, no tonic action is observed, and even if added over 1.0% by weight, no remarkable difference in effect is observed.
更にチコリ・エキスの使用量が5.5重量％未満では、免
疫賦活性が劣り、10重量％を越えて添加しても、特に効
果上の差異は認められない。Further, if the amount of chicory extract used is less than 5.5% by weight, the immunostimulatory activity is inferior, and even if added over 10% by weight, no particular difference in effect is observed.
更に乳糖の使用量が30重量％に満たないと、後述するよ
うな顆粒や錠剤への賦型性が低下し、38重量％を越えて
添加すると、凍結乾燥ケフイアや補助剤の増量過大とな
る。Furthermore, if the amount of lactose used is less than 30% by weight, the moldability to granules or tablets will be reduced as described below, and if it is added in excess of 38% by weight, the amount of freeze-dried kefir or adjuvant will be excessively increased. .
また、澱粉は、体内に摂取された他成分の溶解を促進す
る機能を有すると共に、増量、賦形剤として使用される
ものであり、その使用量が10重量％未満では、増量、賦
形効果が低下し、18重量％を越えて添加しても差異は認
められない。In addition, starch has the function of promoting the dissolution of other components ingested in the body, and is used as an amount increasing or excipient. If the amount used is less than 10% by weight, the amount increasing effect and the shaping effect are obtained. Is decreased, and no difference is observed even if added over 18% by weight.
更に本発明においては、砂糖等の甘味料、着色剤、保存
剤を適宜添加することもできる。Further, in the present invention, a sweetener such as sugar, a coloring agent, and a preservative may be added as appropriate.
次に、かかる本発明の健康食品の製造方法を顆粒状に成
形する場合を例に説明する。Next, the case of forming the health food manufacturing method of the present invention into a granule will be described as an example.
まず、上記したような補助剤および賦形剤をそれぞれ秤
量し、混合すると共に水エタノールを添加して練り合せ
る。First, the above-mentioned auxiliary agents and excipients are weighed and mixed, and water ethanol is added and kneaded.
この練り合せ物を1mmφのスクリーンを通して造粒し、
造粒物を60〜80℃で１時間、乾燥する。得られた乾燥物
を12メツシュのスクリーンで整粒し、更に12メツシュの
スクリーンを篩過させる。Granulate this kneaded product through a 1 mmφ screen,
The granulate is dried at 60-80 ° C for 1 hour. The obtained dried product is sized with a 12-mesh screen, and then screened with a 12-mesh screen.
一方、概要下記のようにして凍結乾燥ケフイアを製造す
る。On the other hand, a freeze-dried kefir is manufactured as follows.
すなわち、まず構成菌が休眠状態にあるケフイア粒を、
通常では牛乳中で20〜25℃で培養し、数回継代してケフ
イア粒を活性化する。That is, first, the kefir grains in which the constituent bacteria are in a dormant state,
Usually, it is cultivated in milk at 20 to 25 ° C and subcultured several times to activate kefir grains.
次に活性化したケフイア粒からケフイア・スターターを
調整する。The kefir starter is then prepared from the activated kefir grains.
この調整は、活性化したケフイア粒を生乳に入れて培養
し、篩で濾過する。篩下として得られた濾過液がケフイ
ア・スターターであり、このスターターを生乳、生乳と
粉乳または練乳等の乳製品との混合乳に接種して培養す
ると発酵乳ケフイアが得られる。For this adjustment, activated kefir grains are put into raw milk, cultivated, and filtered through a sieve. The filtrate obtained under the sieve is a kefir starter, and fermented milk kefir can be obtained by inoculating this starter to raw milk or a mixed milk of raw milk and milk products such as powdered milk or condensed milk.
得られた発酵乳ケフイアを凍結乾燥すると、粉末状の凍
結乾燥ケフイアが得られ、これを更に顆粒状に成形す
る。The obtained fermented milk kefir is freeze-dried to obtain a powdery freeze-dried kefir, which is further molded into granules.
この成形は、たとえば上記同様にして行うことができ
る。This molding can be performed, for example, in the same manner as above.
最後に上記のようにして顆粒状にそれぞれ調整された凍
結乾燥ケフイアおよび他の成分を、それぞれ秤量し、混
合すれば本発明の健康食品が得られる。Finally, the freeze-dried kefir and other components, which have been adjusted in the granular form as described above, are weighed and mixed to obtain the health food of the present invention.
また、大腸菌、一般生菌の検査が、適宜実施される。In addition, tests for E. coli and general viable bacteria are carried out as appropriate.
更に必要に応じて一定量づつ秤量し、たとえばブラスチ
ツクフイルム製の袋に分包すれば、市販、摂取に好適を
製品形態とすることができる。Further, if necessary, a certain amount is weighed, and if it is packaged in a plastic film bag, for example, the product form suitable for commercial use and ingestion can be obtained.
なお、上記製造方法の例では、製品形態が顆粒の場合に
ついて述べたが、本発明はこれに限定されるものではな
く、錠剤に成形しても良いし、或いは造粒工程を省略し
ても粉体状とすることもできる。In the example of the above manufacturing method, the case where the product form is granules has been described, but the present invention is not limited to this, and it may be formed into a tablet or the granulation step may be omitted. It can also be in powder form.
本発明の健康食品の摂取量は、通常では2.5〜3.0g/日程
度であり、上記のように顆粒状に調整し、分包してあれ
ば摂取の際に飛び散ることがないので好ましい。The intake amount of the health food of the present invention is usually about 2.5 to 3.0 g / day, and it is preferable that the health food is adjusted to the granular form as described above and is packaged so that it does not scatter upon ingestion.
或いは顆粒状の製品を瓶詰めとした場合には、計量スプ
ーン等によつて一定量を摂取することもできる。Alternatively, when the granular product is bottled, a certain amount can be ingested with a measuring spoon or the like.
また、添加される補助剤の種類および量によつても異な
るが、灰白色〜灰褐色であり、乳状の芳香と風味を有し
ているので抵抗感も少なく、かつ長期間の保存でも変化
は認められない。Also, although it varies depending on the type and amount of the auxiliary agent added, it is grayish white to grayish brown and has a milky aroma and flavor, so there is little resistance, and changes are observed even after long-term storage. I can't.
以上述べたように本発明の健康食品によれば、凍結乾燥
ケフイアが含有されているので、この凍結乾燥ケフイア
が本来有していた抗腫瘍活性、抗血栓症作用および免疫
賦活効果等の生理効果を、そのまま保存している。As described above, according to the health food of the present invention, since it contains freeze-dried kefir, the anti-tumor activity originally possessed by this freeze-dried kefir, physiological effects such as antithrombotic effect and immunostimulatory effect. Is stored as is.
これらの結果、特に抗腫瘍活性はマイトマイシンに匹敵
するものであり、注目に値し、しかも凍結乾燥ケフイア
は、ケフイア・ヨーグルトを凍結乾燥してものなので、
マイトマイシンのような副作用等を全く考慮する必要が
なく、従来の健康食品と同様に好適に使用することがで
きる。These results show that the antitumor activity is comparable to that of mitomycin, and it is noteworthy that freeze-dried kefir can be obtained by freeze-drying kefir yogurt.
There is no need to consider side effects such as mitomycin at all, and it can be preferably used like conventional health foods.
更に加えて本発明においては、冷凍乾燥ケフイア以外に
補助剤としてエゾウコギ・エキス、トナカイ角粉末およ
びチコリ・エキスから選ばれた少なくとも１種が添加さ
れているので、この補助剤に対応した特有の生理効果、
すなわちエゾウコギ・エキスであれば血粒改善効果、ト
ナカイ角粉末であれば強壮効果、またチコリ・エキスで
あれば免疫賦活効果等の生理効果が発揮される。Furthermore, in the present invention, in addition to freeze-dried kefir, at least one selected from eleuthero extract, reindeer horn powder and chicory extract is added as an auxiliary agent. effect,
That is, the eleuthero extract has a blood grain improving effect, the reindeer horn powder has a tonic effect, and the chicory extract has an immunostimulating effect.
しかも本発明の健康食品では、賦形剤の添加によつて、
例えば顆粒状に成形することができ、凍結乾燥ケフイア
が有する乳状の芳香と味が保持されているので、おいし
く、所定の量を食することができる。Moreover, in the health food of the present invention, by the addition of the excipient,
For example, it can be formed into granules and retains the milky aroma and taste of freeze-dried kefir, so it is delicious and can be eaten in a predetermined amount.
以下、本発明の実施例を述べる。Examples of the present invention will be described below.
下記第３表に示す配合比率の顆粒状の健康食品を製造し
た。Granular health foods having the compounding ratios shown in Table 3 below were produced.
第３表 凍結乾燥ケフイア・・ 1000 mg エゾウコギ・エキス・・ 81.90 mg トナカイ角粉末・・ 17.55 mg チコリ・エキス・・・ 234.00 mg 乳糖・・ 833.275mg 澱粉・・ 333.275mg 即ち、この第３表の比率で各成分を混合し、十分に混合
した後に顆粒状に成形した。Table 3 Freeze-dried kefir ... 1000 mg Eleuthero extract ... 81.90 mg Reindeer horn powder ... The respective components were mixed with each other, thoroughly mixed, and then formed into a granular shape.
得られたものは、淡褐色で乳状の香りと味を有していて
美味であり、抵抗感なく摂取することができた。The obtained product was light brown, had a milky aroma and taste and was delicious, and could be ingested without resistance.
Claims (1)
よび賦形剤とからなり、該補助剤がエゾウコギエキス、
トナカイ角粉末およびチコリ・エキスから選ばれた少な
くとも１種であることを特徴とする健康食品。1. A freeze-dried kefir yogurt, an adjuvant and an excipient, wherein the adjuvant is an eleuthero extract,
A health food comprising at least one selected from reindeer horn powder and chicory extract.
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61026671A JPH07121195B2 (en) | 1986-02-12 | 1986-02-12 | healthy food |
| US06/914,835 US4702923A (en) | 1985-10-08 | 1986-10-02 | Lyophilized kefir yoghurt health food |
| GB8624057A GB2184334B (en) | 1985-10-08 | 1986-10-07 | A process for the production of lyophilized kefir yoghurt,and health food containing the same as main ingredient |
| KR1019860008446A KR930002022B1 (en) | 1985-10-08 | 1986-10-08 | Process for the production of kefir yoghurt |
| US07/036,935 US4797290A (en) | 1985-10-08 | 1987-04-10 | Lyophilized process for the production of a kefir yoghurt |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61026671A JPH07121195B2 (en) | 1986-02-12 | 1986-02-12 | healthy food |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62186741A JPS62186741A (en) | 1987-08-15 |
| JPH07121195B2 true JPH07121195B2 (en) | 1995-12-25 |
Family
ID=12199861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61026671A Expired - Fee Related JPH07121195B2 (en) | 1985-10-08 | 1986-02-12 | healthy food |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH07121195B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007117094A (en) * | 2007-01-15 | 2007-05-17 | Nippon Kefia Kk | Health food containing milk fermented product and herb |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54129163A (en) * | 1978-03-28 | 1979-10-06 | Fujiya Kk | Production of instant yogurt powder |
| JPS55159752A (en) * | 1979-05-31 | 1980-12-12 | Morinaga & Co Ltd | Preparation of solid fermentation milk |
| JP3161369B2 (en) * | 1997-06-12 | 2001-04-25 | 日本電気株式会社 | Network management information collection method |
-
1986
- 1986-02-12 JP JP61026671A patent/JPH07121195B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62186741A (en) | 1987-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101341949B (en) | Various grains chewing slice and preparation method thereof | |
| CN102599322A (en) | Tablet candy suitable for children and manufacturing method thereof | |
| CN102813207A (en) | Formula and preparation process of corn peptide chewable tablets | |
| JP3280247B2 (en) | Natto food | |
| JP3382820B2 (en) | Health foods mainly composed of physiologically active substances | |
| WO2002021941A1 (en) | Novel vinegar marine algae powder or grains and process for producing the same | |
| CN101904537A (en) | Method for producing medicinal granules with hypotensive effect by utilizing by-product obtained by producing purple sweet potato starch | |
| JPH07121195B2 (en) | healthy food | |
| KR101834638B1 (en) | The method of functional korea traditional cracker using the jujube | |
| CN109730303A (en) | A kind of endothelium corneum gigeriae galli crystallite medicinal granules of powder of food digesting stomach fortifying and preparation method thereof | |
| KR20090059270A (en) | Tea using phellinus linteus and manufacturing method thereof | |
| JP2006191917A (en) | Mixed powder given by using cauline leaf part and tuberous root part of yacon as raw material, method for producing the same, and pill or tablet obtained from the same | |
| KR102206967B1 (en) | Hangover curing agent comprising dendropanax morbifera and method for preparation thereof | |
| KR101994458B1 (en) | Manufacturing method of grain syrup using chestnut inner bark | |
| KR101836940B1 (en) | Manufacture method of cold arrowroot noodle having black ginseng | |
| JP2001103927A (en) | Method of producing agaricus blazei murill extract having high antitumor activity | |
| JP4677521B2 (en) | Tartary buckwheat-containing solid food, method for producing the same, and binder | |
| JPS59106276A (en) | Health food | |
| JPH1189512A (en) | Health hood | |
| KR20190098429A (en) | Method of Manufacturing Tablet Products using Milk Thistle and White Spotted Flowers Larvae | |
| JPS5959177A (en) | Food containing bacillus natto and lactobacillus | |
| US5523086A (en) | Method for manufacturing a health food utilizing a garlic | |
| KR102531295B1 (en) | Manufacturing method of food composition for immune-enhancing activity comprising juice of Cirsium setidens, and food composition for immune-enhancing activity using thereby | |
| JP7017749B2 (en) | Anti-allergic agents and food compositions for the prevention or treatment of allergic diseases | |
| KR101817621B1 (en) | Method for preparing functional grain syrup comprising spring onion root |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |